Einträge von Güresir, Erdem auf dem Publikationsserver

Güresir, Erdem, Lampmann, Tim , Bele, Sylvia, Czabanka, Marcus, Czorlich, Patrick , Gempt, Jens, Goldbrunner, Roland, Hurth, Helene, Hermann, Elvis, Jabbarli, Ramazan, Krauthausen, Marius, König, Ralph, Lindner, Dirk, Malinova, Vesna, Meixensberger, Jürgen, Mielke, Dorothee, Németh, Robert, Darkwah Oppong, Marvin , Pala, Andrej, Prinz, Vincent, Rashidi, Ali, Roder, Constantin, Sandalcioglu, Ibrahim Erol, Sauvigny, Thomas, Schebesch, Karl-Michael, Timmer, Marco, Vajkoczy, Peter, Wessels, Lars, Wild, Florian, Wilhelm, Christoph, Wostrack, Maria , Vatter, Hartmut und Coch, Christoph (2023) Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: Study protocol for a randomized controlled trial. International Journal of Stroke 18 (2), S. 242-247. Volltext nicht vorhanden.

Weller, Johannes , Schäfer, Niklas, Schaub, Christina, Potthoff, Anna-Laura, Steinbach, Joachim P., Schlegel, Uwe, Sabel, Michael , Hau, Peter , Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Pietsch, Torsten, Tzaridis, Theophilos, Zeyen, Thomas, Borger, Valeri, Güresir, Erdem, Vatter, Hartmut, Herrlinger, Ulrich und Schneider, Matthias (2022) Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS. Journal of Neuro-Oncology 159 (1), S. 95-101.

Zeyen, Thomas, Potthoff, Anna-Laura, Nemeth, Robert, Heiland, Dieter H., Burger, Michael C., Steinbach, Joachim P., Hau, Peter, Tabatabai, Ghazaleh, Glas, Martin, Schlegel, Uwe, Grauer, Oliver, Krex, Dietmar, Schnell, Oliver, Goldbrunner, Roland, Sabel, Michael , Thon, Niklas, Delev, Daniel, Clusmann, Hans, Seidel, Clemens, Güresir, Erdem, Schmid, Matthias , Schuss, Patrick , Giordano, Frank A., Radbruch, Alexander, Becker, Albert, Weller, Johannes, Schaub, Christina, Vatter, Hartmut, Schilling, Judith, Winkler, Frank , Herrlinger, Ulrich und Schneider, Matthias (2022) Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial. Trials 23 (1). Volltext nicht vorhanden.

Güresir, Erdem, Lampmann, Tim, Brandecker, Simon, Czabanka, Marcus, Fimmers, Rolf, Gempt, Jens, Haas, Patrick, Haj, Amer, Jabbarli, Ramazan, Kalasauskas, Darius, König, Ralph, Mielke, Dorothee, Németh, Robert, Oppong, Marvin Darkwah , Pala, Andrej, Prinz, Vincent, Ringel, Florian, Roder, Constantin, Rohde, Veit, Schebesch, Karl-Michael, Wagner, Arthur , Coch, Christoph und Vatter, Hartmut (2022) PrImary decompressive Craniectomy in AneurySmal Subarachnoid hemOrrhage (PICASSO) trial: study protocol for a randomized controlled trial. Trials 23 (1). Volltext nicht vorhanden.

Wessels, Lars, Fekonja, Lucius Samo , Achberger, Johannes, Dengler, Julius, Czabanka, Marcus, Hecht, Nils, Schneider, Ulf, Tkatschenko, Dimitri, Schebesch, Karl-Michael, Schmidt, Nils Ole , Mielke, Dorothee, Hosch, Henning, Ganslandt, Oliver, Gräwe, Alexander, Hong, Bujung, Walter, Jan, Güresir, Erdem, Bijlenga, Philippe, Haemmerli, Julien, Maldaner, Nicolai, Marbacher, Serge, Nurminen, Ville , Zitek, Hynek, Dammers, Ruben, Kato, Naoki, Linfante, Italo, Pedro, Maria-Teresa, Wrede, Karsten, Wang, Wei-Te, Wostrack, Maria und Vajkoczy, Peter (2020) Diagnostic reliability of the Berlin classification for complex MCA aneurysms—usability in a series of only giant aneurysms. Acta Neurochirurgica 162 (11), S. 2753-2758.